Development of automated microfluidic immunoassays for the detection of SARS-CoV-2 antibodies and antigen
Description
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease 2019 (COVID-19) global pandemic. Rapid and sensitive detection of the virus soon after infection is important for the treatment and
